BML Investment Partners, L.P. 13D and 13G filings for Reneo Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-21 10:12 am Purchase | 2024-05-21 | 13G | RENEO PHARMACEUTICALS INC RPHM | BML Investment Partners, L.P. | 369,296 11.000% | 199,873 (+117.97%) | Filing |
| 2024-01-16 5:54 pm Purchase | 2024-01-10 | 13G | RENEO PHARMACEUTICALS INC RPHM | BML Investment Partners, L.P. | 169,423 5.100% | 169,423 (New Position) | Filing |